
AI finds more breast tumors earlier than traditional double radiologist review
This has been demonstrated by researchers led by Radboud university medical center in a study published in The Lancet Digital Health

This has been demonstrated by researchers led by Radboud university medical center in a study published in The Lancet Digital Health

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment.

WEST DUNDEE, Ill., Aug. 14, 2025 /PRNewswire/ — Those seeking help with depression or anxiety can now benefit from an FDA-cleared, medication-free procedure at Dundee Dermatology. The center is showcasing EXOMIND, a noninvasive neurostimulation device that enhances mental wellness.

The test was previously granted a breakthrough device designation by the US regulator.

Now, researchers publishing in ACS Applied Polymer Materials have created a reusable hydrogel that releases artificial saliva over time, which could help provide sustained relief from dry mouth.

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School of Medicine and the Wharton School at the University of Pennsylvania can analyze kidney disease at the cellular level to match the most effective treatments and speed up solutions.

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while maintaining low recall rates, according to a study published in Radiology.

Researchers have shown in Frontiers in Digital Health that abnormalities of the vocal folds can be detected from the sound of the voice.

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network.

Electroretinography (ERG) is an ophthalmic diagnostic method used to determine whether the retina is functioning normally. It is widely employed for diagnosing hereditary retinal diseases or assessing retinal function decline.